To say companies in the healthcare ­sector are fit and growing is to acknowledge that people are sick and dying.

But if Australia’s providers of medical care, pharmaceuticals and procedures have glowing prospects, it is because more people around the world will be able to afford to treat the ills of modern life that creep up on them. Companies with offshore operations will also benefit as the dollar falls.